Product Information

CLIND PH-BENZOYL PERO 1.2-2.5% is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.9098 per GM under NDC 51672136703. Its NADAC has been published 369 times since Oct 23, 2019.

FDA first approved this application on Aug 19, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CLIND PH-BENZOYL PERO 1.2-2.5%

Clindamycin Phosphate and Benzoyl Peroxide
$0.9098per GM

Strength

25; 10 mg/g; mg/g

NDC

51672136703

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

10/21/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA206575

FDA Approved

8/19/2019

TE Code

AB

On Market Since

8/19/2019

Pharmacological Classes

Decreased Sebaceous Gland Activity
Lincosamide Antibacterial
Lincosamides
Neuromuscular Blockade

Price Statistics

The NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has been published 369 times since Oct 23, 2019, and over the history we have for it it has declined 87.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.9098 per GM
All-time high$7.4004 (Mar 11, 2020)
All-time low$0.6671 (Jul 22, 2026)
52-week high$0.9098
52-week low$0.6671
Median price$1.2892
Average price$1.6712
Largest weekly change+71.0% (Feb 22, 2023)
Weeks tracked369
Tracking sinceOct 23, 2019

Price History

1W

0.0%

1M

+11.1%

3M

+36.4%

6M

+9.0%

1Y

+7.4%

3Y

-29.6%

5Y

-28.5%

All

-87.7%

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of CLIND PH-BENZOYL PERO 1.2-2.5%?

The current National Average Drug Acquisition Cost (NADAC) for CLIND PH-BENZOYL PERO 1.2-2.5%, manufactured by Sun Pharmaceutical Industries Inc., is $0.9098 per GM (NDC 51672136703), effective Nov 11, 2026.

How has the price of CLIND PH-BENZOYL PERO 1.2-2.5% changed over time?

Over the history we have for it, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has declined 87.7%. It has been tracked across 369 weekly CMS publications since Oct 23, 2019.

What are the highest and lowest recorded NADAC prices for CLIND PH-BENZOYL PERO 1.2-2.5%?

Since Oct 23, 2019, the NADAC for CLIND PH-BENZOYL PERO 1.2-2.5% has ranged from a low of $0.6671 (Jul 22, 2026) to a high of $7.4004 (Mar 11, 2020), with a median of $1.2892 per GM.

Are there cheaper alternatives to CLIND PH-BENZOYL PERO 1.2-2.5%?

2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLIND PH-BENZOYL PERO 1.2-2.5% in a comparable dosage form, but none are currently priced below it.

Who manufactures CLIND PH-BENZOYL PERO 1.2-2.5%?

CLIND PH-BENZOYL PERO 1.2-2.5% (NDC 51672136703) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.